Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Psychiatry Reports
Erschienen in: Current Psychiatry Reports 3/2010

01.06.2010

Psychiatric Aspects of Amyotrophic Lateral Sclerosis (ALS)

verfasst von: Lorenzo Norris, Guinevere Que, Elham Bayat

Erschienen in: Current Psychiatry Reports | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive disorder characterized by degeneration of motor neurons. Given the severe nature of ALS, many believed that patients would suffer from a high level of depression and a low quality of life. However, research into the psychological health of patients with ALS has shown that this is not the case. This article reviews the state of current knowledge as it pertains to the psychological health of ALS patients in four broad areas: quality of life, personality characteristics, emotional reactions, and end-of-life choices.
Literatur
1.
•• Averill AJ, Kasarskis EJ, Segerstrom SC: Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007, 8:243–254. In this recent review, the authors do a superb job of summarizing many of the current studies involving ALS and depression. In addition, they present a very informative summary table that discusses the merits of all 28 studies.CrossRefPubMed
2.
Hillemacher T, Grassel E, Tigges S, et al.: Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:245–249.CrossRefPubMed
3.
Lomen-Hoerth C, Anderson T, Miller B: The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002, 59:1077–1079.CrossRefPubMed
4.
Vignola A, Guzzo A, Calvo A, et al.: Anxiety undermines quality of life in ALS patients and caregivers. Eur J Neurol 2008, 15:1231–1236.CrossRefPubMed
5.
Murphy JM, Henry RG, Langmore S, et al.: Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007, 64:530–534.CrossRefPubMed
6.
Murphy J, Henry R, Lomen-Hoerth C: Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007, 64:330–334.CrossRefPubMed
7.
Rabkin JG, Wagner GJ, Del Bene M: Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 2000, 62:271–279.PubMed
8.
Rabkin JG, Albert SM, Tider T, et al.: Predictors and course of elective long-term mechanical ventilation: a prospective study of ALS patients. Amyotroph Lateral Scler 2006, 7:86–95.CrossRefPubMed
9.
Rabkin JG, Albert SM, Del Bene ML, et al.: Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 2005, 65:62–67.CrossRefPubMed
10.
McElhiney MC, Rabkin JG, Gordon PH, et al.: Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry 2009, 80:1146–1149.CrossRefPubMed
11.
Kubler A, Winter S, Ludolph AC, et al.: Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair 2005, 19:182–193.CrossRefPubMed
12.
Lomen-Hoerth C: Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord 2004, 17:337–341.CrossRefPubMed
13.
Lomen-Hoerth C, Murphy J, Langmore S, et al.: Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003, 60:1094–1097.PubMed
14.
Coons SJ, Rao S, Keininger DL, Hays RD: A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000, 17:13–35.CrossRefPubMed
15.
Jenkinson C, Fitzpatrick R, Swash M, Peto V; ALS-HPS Steering Group: The ALS health profile study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe. J Neurol 2000, 247:835–840.CrossRefPubMed
16.
Jenkinson C, Hobart J, Chandola T, et al.: Use of the Short Form Health Survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol 2002, 249:178–183.CrossRefPubMed
17.
Simmons Z, Bremer BA, Robbins RA, et al.: Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000, 55:388–392.PubMed
18.
Simmons Z, Felgoise SH, Bremer BA, et al.: The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology 2006, 67:1659–1664.CrossRefPubMed
19.
Nelson ND, Trail M, Van JN, et al.: Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics. J Palliat Med 2003, 6:417–424.CrossRefPubMed
20.
21.
Epton J, Harris R, Jenkinson C: Quality of life in amyotrophic lateral sclerosis/motor neuron disease: a structured review. Amyotroph Lateral Scler 2009, 10:15–26.CrossRefPubMed
22.
Chio A, Gauthier A, Montuschi A, et al.: A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry 2004, 75:1597–1601.CrossRefPubMed
23.
Neudert C, Wasner M, Borasio GD: Patients’ assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001, 191:103–109.CrossRefPubMed
24.
•• Roach AR, Averill AJ, Segerstrom SC, Kasarskis EJ: The dynamics of quality of life in ALS patients and caregivers. Ann Behav Med 2009, 37:197–206. This was the first article to examine how QOL changes over time. To this point, QOL assessments were essentially snapshots. This article and others introduced the idea that QOL changes in ALS, and these changes must be taken into account.CrossRefPubMed
25.
Koenig HG, George LK, Peterson BL, Pieper CF: Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry 1997, 154:1376–1383.PubMed
26.
Clarke DM, Smith GC, Herrman HE: A comparative study of screening instruments for mental disorders in general hospital patients. Int J Psychiatry Med 1993, 23:323–337.PubMed
27.
Clarke DM, Kissane DW, Trauer T, Smith GC: Demoralization, anhedonia and grief in patients with severe physical illness. World Psychiatry 2005, 4:96–105.PubMed
28.
Clarke DM, Cook K, Smith GC, Piterman L: What do general practitioners think depression is? A taxonomy of distress and depression for general practice. Med J Aust 2008, 188(12 Suppl):S110–S113.PubMed
29.
Lazarus RS: From psychological stress to the emotions: a history of changing outlooks. Annu Rev Psychol 1993, 44:1–21.CrossRefPubMed
30.
Nichols SE: Psychosocial reactions of persons with the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:765–767.PubMed
31.
Lou JS, Reeves A, Benice T, Sexton G: Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003, 60:122–123.PubMed
32.
Trail M, Nelson ND, Van JN, et al.: A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003, 209:79–85.CrossRefPubMed
33.
Wicks P, Abrahams S, Masi D, et al.: Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol 2007, 14:993–1001. (Published erratum appears in Eur J Neurol 2008, 15:1009.)
34.
Gauthier A, Vignola A, Calvo A, et al.: A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology 2007, 68:923–926.CrossRefPubMed
35.
Passik SD, Roth AJ: Anxiety symptoms and panic attacks preceding pancreatic cancer diagnosis. Psychooncology 1999, 8:268–272.CrossRefPubMed
36.
Cloninger CR: The psychobiological theory of temperament and character: comment on Farmer and Goldberg (2008). Psychol Assess 2008, 20:292–299; discussion 300–304.
37.
Cloninger CR: How does personality influence mortality in the elderly? Psychosom Med 2005, 67:839–840.CrossRefPubMed
38.
Cloninger CR, Svrakic DM, Przybeck TR: Can personality assessment predict future depression? A twelve-month follow-up of 631 subjects. J Affect Disord 2006, 92:35–44.CrossRefPubMed
39.
Grossman AB, Levin BE, Bradley WG: Premorbid personality characteristics of patients with ALS. Amyotroph Lateral Scler 2006, 7:27–31.CrossRefPubMed
40.
Krampe H, Bartels C, Victorson D, et al.: The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotroph Lateral Scler 2008, 9:99–107.CrossRefPubMed
41.
Beck AT, Weissman A, Lester D, Trexler L: The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol 1974, 42:861–865.CrossRefPubMed
42.
•• Miglioretti M, Mazzini L, Oggioni GD, et al.: Illness perceptions, mood and health-related quality of life in patients with amyotrophic lateral sclerosis. J Psychosom Res 2008, 65:603–609. This article took a critical look at illness perceptions in ALS. In many ways, it was bringing together the observations of others, such as Plathua and Lazarus. Of note, this article also identified standing variables with which patients assess their current state.CrossRefPubMed
43.
Browne GB, Byrne C, Roberts J, et al.: The Meaning of Illness Questionnaire: reliability and validity. Nurs Res 1988, 37:368–373.CrossRefPubMed
44.
Folkman S, Lazarus RS: The relationship between coping and emotion: implications for theory and research. Soc Sci Med 1988, 26:309–317.CrossRefPubMed
45.
Folkman S, Lazarus RS, Gruen RJ, DeLongis A: Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol 1986, 50:571–579.CrossRefPubMed
46.
Plahuta JM, McCulloch BJ, Kasarskis EJ, et al.: Amyotrophic lateral sclerosis and hopelessness: psychosocial factors. Soc Sci Med 2002, 55:2131–2140.CrossRefPubMed
47.
Fanos JH, Gelinas DF, Foster RS, et al.: Hope in palliative care: from narcissism to self-transcendence in amyotrophic lateral sclerosis. J Palliat Med 2008, 11:470–475.CrossRefPubMed
48.
Goldstein LH, Atkins L, Landau S, et al.: Longitudinal predictors of psychological distress and self-esteem in people with ALS. Neurology 2006, 67:1652–1658.CrossRefPubMed
49.
Centers LC: Beyond denial and despair: ALS and our heroic potential for hope. J Palliat Care 2001, 17:259–264.PubMed
50.
•• Maessen M, Veldink JH, Onwuteaka-Philipsen BD, et al.: Trends and determinants of end-of-life practices in ALS in the Netherlands. Neurology 2009, 73:954–961. This is a very important article that gives insight into the end-of-life choices in those with ALS. It basically shows that those with ALS who opt for PAS are for the most part not depressed. This along with the work of Rabkin et al. further argues against the idea of MDD being an inevitable psychosocial outcome of ALS.CrossRefPubMed
Metadaten
Titel
Psychiatric Aspects of Amyotrophic Lateral Sclerosis (ALS)
verfasst von
Lorenzo Norris
Guinevere Que
Elham Bayat
Publikationsdatum
01.06.2010
Verlag
Current Science Inc.
Erschienen in
Current Psychiatry Reports / Ausgabe 3/2010
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-010-0118-6

Weitere Artikel der Ausgabe 3/2010

Current Psychiatry Reports 3/2010 Zur Ausgabe

ReviewPaper

Inflammatory Bowel Disease in Children: Psychological and Psychiatric Issues

ReviewPaper

The Impact of Depression in Heart Disease

ReviewPaper

Differentiation Between Demoralization, Grief, and Anhedonic Depression

ReviewPaper

Religion, Spirituality, and Psychosis

ReviewPaper

Borderline Personality Disorder and Psychosis: A Review

ReviewPaper

Anticoagulation and Psychotropic Medications

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise